These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
619 related items for PubMed ID: 18307680
1. Role of alpha1-blockers in chronic prostatitis syndromes. Nickel JC. BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680 [Abstract] [Full Text] [Related]
3. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials. Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q. J Androl; 2006 Jun; 27(6):847-52. PubMed ID: 16870951 [Abstract] [Full Text] [Related]
4. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. Nickel JC, Narayan P, McKay J, Doyle C. J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228 [Abstract] [Full Text] [Related]
6. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. Nickel JC, Downey J, Johnston B, Clark J, Canadian Prostatitis Research Group. J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913 [Abstract] [Full Text] [Related]
7. Frequent ejaculation associated free radical and lactic acid accumulation cause noninfectious inflammation and muscle dysfunction: a potential mechanism for symptoms in Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Peng H, Chen Q, Tan Y. Med Hypotheses; 2009 Sep; 73(3):372-3. PubMed ID: 19435656 [Abstract] [Full Text] [Related]
8. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ. Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740 [Abstract] [Full Text] [Related]
9. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. Shoskes DA, Thomas KD, Gomez E. J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213 [Abstract] [Full Text] [Related]
10. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Shoskes DA, Nickel JC, Kattan MW. Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491 [Abstract] [Full Text] [Related]
11. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. Nickel JC, Downey J, Ardern D, Clark J, Nickel K. J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727 [Abstract] [Full Text] [Related]
12. Identification, pharmacologic considerations, and management of prostatitis. Schiller DS, Parikh A. Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307 [Abstract] [Full Text] [Related]
13. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. Xia D, Wang P, Chen J, Wang S, Jiang H. Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619 [Abstract] [Full Text] [Related]
14. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, Kurtuluş F, Cek M. Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960 [Abstract] [Full Text] [Related]
15. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. Nickel JC, Elhilali M, Emberton M, Vallancien G, Alf-One Study Group. BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719 [Abstract] [Full Text] [Related]
16. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591 [Abstract] [Full Text] [Related]
17. [Combined therapy for the chronic pelvic pain syndrome]. Xu S, Qi G, Tang P, Li Y. Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206 [Abstract] [Full Text] [Related]
18. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN. Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470 [Abstract] [Full Text] [Related]
19. [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome]. Yan S, Li HZ, Zhang XY, Li HJ. Zhonghua Nan Ke Xue; 2009 Aug; 15(8):717-20. PubMed ID: 19852273 [Abstract] [Full Text] [Related]
20. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM, Litwin MS, Chronic Prostatitis Collaborative Research Network. Ann Intern Med; 2004 Oct 19; 141(8):581-9. PubMed ID: 15492337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]